Brief: FDA grants orphan-drug designation for Regenicin's Novaderm cultured skin substitute
Aug 29 (Reuters) - Regenicin Inc RGIN.PK
* FDA grants drug designation for Regenicin's Novaderm
cultured skin substitute
Source text for Eikon: ID:nPn6JH7tXa
Further company coverage: RGIN.PK
((Bangalore.newsroom@thomsonreuters.com;))